Vitamin D has a better binding capacity to IL-13 than the common asthma medication mometasone(32), which suggests that vitamin D could be used for increased inhibition of IL-13 in asthmatics leading to a reduced inflammatory response. This evidence concerns the gene IL13 and asthma.